Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.93711449 |
2 | negative regulation of cell killing (GO:0031342) | 6.93711449 |
3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.31183867 |
4 | NIK/NF-kappaB signaling (GO:0038061) | 6.21728550 |
5 | interferon-gamma production (GO:0032609) | 6.05117849 |
6 | negative T cell selection (GO:0043383) | 5.23830300 |
7 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.18521044 |
8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.13573824 |
9 | regulation of gamma-delta T cell activation (GO:0046643) | 5.04238423 |
10 | response to interleukin-15 (GO:0070672) | 5.01732730 |
11 | cellular response to interleukin-15 (GO:0071350) | 4.97584095 |
12 | negative thymic T cell selection (GO:0045060) | 4.94256018 |
13 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.83550803 |
14 | positive thymic T cell selection (GO:0045059) | 4.76547140 |
15 | T-helper cell differentiation (GO:0042093) | 4.73247966 |
16 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 4.73247966 |
17 | positive T cell selection (GO:0043368) | 4.59856955 |
18 | T cell selection (GO:0045058) | 4.32289153 |
19 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.29627885 |
20 | * response to muramyl dipeptide (GO:0032495) | 4.28007513 |
21 | thymic T cell selection (GO:0045061) | 4.25128772 |
22 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 4.16219926 |
23 | alpha-beta T cell activation involved in immune response (GO:0002287) | 4.16219926 |
24 | T cell differentiation involved in immune response (GO:0002292) | 4.16219926 |
25 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.09793110 |
26 | embryonic process involved in female pregnancy (GO:0060136) | 3.99308908 |
27 | T cell migration (GO:0072678) | 3.95617667 |
28 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.92904464 |
29 | alpha-beta T cell activation (GO:0046631) | 3.91686072 |
30 | alpha-beta T cell differentiation (GO:0046632) | 3.90491376 |
31 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.86827084 |
32 | viral protein processing (GO:0019082) | 3.86338482 |
33 | negative regulation of interleukin-12 production (GO:0032695) | 3.79760738 |
34 | positive regulation of interleukin-2 production (GO:0032743) | 3.77089174 |
35 | leukocyte aggregation (GO:0070486) | 3.72086721 |
36 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.70716925 |
37 | positive regulation of heat generation (GO:0031652) | 3.70578256 |
38 | regulation of T cell tolerance induction (GO:0002664) | 3.70542716 |
39 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.70325345 |
40 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.70325345 |
41 | cellular response to type I interferon (GO:0071357) | 3.68447377 |
42 | type I interferon signaling pathway (GO:0060337) | 3.68447377 |
43 | response to type I interferon (GO:0034340) | 3.64763106 |
44 | myeloid dendritic cell activation (GO:0001773) | 3.61849551 |
45 | myeloid dendritic cell differentiation (GO:0043011) | 3.58705331 |
46 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.53426839 |
47 | T cell receptor signaling pathway (GO:0050852) | 3.51415579 |
48 | regulation of fever generation (GO:0031620) | 3.51056173 |
49 | positive regulation of isotype switching (GO:0045830) | 3.50943728 |
50 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.50384334 |
51 | mature B cell differentiation (GO:0002335) | 3.47229126 |
52 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.45194389 |
53 | leukocyte cell-cell adhesion (GO:0007159) | 3.43143655 |
54 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.42687679 |
55 | modulation by symbiont of host cellular process (GO:0044068) | 3.42343201 |
56 | T cell activation involved in immune response (GO:0002286) | 3.40230284 |
57 | * tolerance induction (GO:0002507) | 3.39329444 |
58 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.34312698 |
59 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.33873958 |
60 | germinal center formation (GO:0002467) | 3.32292887 |
61 | regulation of response to interferon-gamma (GO:0060330) | 3.29527165 |
62 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.29217689 |
63 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.27726905 |
64 | response to peptidoglycan (GO:0032494) | 3.27227103 |
65 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.26845211 |
66 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.24608620 |
67 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.23337955 |
68 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.22898168 |
69 | positive regulation of humoral immune response (GO:0002922) | 3.17861017 |
70 | positive regulation of B cell differentiation (GO:0045579) | 3.15510476 |
71 | regulation of regulatory T cell differentiation (GO:0045589) | 3.14804049 |
72 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.14669975 |
73 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.14103564 |
74 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.11634160 |
75 | defense response to protozoan (GO:0042832) | 3.09350223 |
76 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.06973945 |
77 | positive regulation of interleukin-12 production (GO:0032735) | 3.06359966 |
78 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.03785512 |
79 | positive regulation of B cell mediated immunity (GO:0002714) | 3.03785512 |
80 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.02524984 |
81 | response to protozoan (GO:0001562) | 3.02497543 |
82 | positive regulation of tolerance induction (GO:0002645) | 3.02381833 |
83 | * regulation of chronic inflammatory response (GO:0002676) | 3.02322014 |
84 | regulation of cell killing (GO:0031341) | 3.01851798 |
85 | negative regulation of T cell mediated immunity (GO:0002710) | 3.01382636 |
86 | neutrophil activation involved in immune response (GO:0002283) | 2.99823346 |
87 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.99643519 |
88 | positive regulation of DNA recombination (GO:0045911) | 2.99275168 |
89 | T cell differentiation (GO:0030217) | 2.98958693 |
90 | regulation of B cell differentiation (GO:0045577) | 2.98920364 |
91 | regulation of alpha-beta T cell activation (GO:0046634) | 2.97767333 |
92 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.97760715 |
93 | mature B cell differentiation involved in immune response (GO:0002313) | 2.97233380 |
94 | regulation of T-helper cell differentiation (GO:0045622) | 2.95961546 |
95 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.95556757 |
96 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.94741603 |
97 | neutrophil activation (GO:0042119) | 2.94482550 |
98 | positive regulation by symbiont of host defense response (GO:0052509) | 2.93874743 |
99 | modulation by symbiont of host defense response (GO:0052031) | 2.93874743 |
100 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.93874743 |
101 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.93874743 |
102 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.93874743 |
103 | modulation by symbiont of host immune response (GO:0052553) | 2.93874743 |
104 | regulation of interferon-alpha production (GO:0032647) | 2.93524134 |
105 | granulocyte activation (GO:0036230) | 2.93050299 |
106 | regulation of alpha-beta T cell differentiation (GO:0046637) | 2.92996196 |
107 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.91830638 |
108 | natural killer cell activation (GO:0030101) | 2.91728639 |
109 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.91677273 |
110 | T cell costimulation (GO:0031295) | 2.91245505 |
111 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.90546400 |
112 | regulation of tolerance induction (GO:0002643) | 2.90135049 |
113 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.90064187 |
114 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.88804045 |
115 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.88574702 |
116 | positive regulation of defense response to virus by host (GO:0002230) | 2.88095615 |
117 | mast cell activation (GO:0045576) | 2.87336981 |
118 | regulation of vitamin metabolic process (GO:0030656) | 2.87271240 |
119 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.86857764 |
120 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.86289936 |
121 | lymphocyte costimulation (GO:0031294) | 2.86183448 |
122 | heterotypic cell-cell adhesion (GO:0034113) | 2.85903538 |
123 | regulation of heat generation (GO:0031650) | 2.82777752 |
124 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.81660488 |
125 | immunoglobulin mediated immune response (GO:0016064) | 2.81582062 |
126 | * regulation of interleukin-2 production (GO:0032663) | 2.81518517 |
127 | positive regulation of p38MAPK cascade (GO:1900745) | 2.79870164 |
128 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.79636084 |
129 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.79636084 |
130 | regulation of interleukin-12 production (GO:0032655) | 2.78867843 |
131 | positive regulation of T cell differentiation (GO:0045582) | 2.78356549 |
132 | regulation of isotype switching (GO:0045191) | 2.78344188 |
133 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.77884178 |
134 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.77838440 |
135 | dendritic cell chemotaxis (GO:0002407) | 2.77786411 |
136 | regulation of chemokine biosynthetic process (GO:0045073) | 2.77560362 |
137 | lymphocyte migration (GO:0072676) | 2.76909816 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.40112196 |
2 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.89040841 |
3 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.20038279 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.06615867 |
5 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 4.04509210 |
6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.46429161 |
7 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 3.36032605 |
8 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.28802868 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.11255430 |
10 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.06359896 |
11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.99831122 |
12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.96280709 |
13 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.81713498 |
14 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.79966746 |
15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.78792991 |
16 | MYB_26560356_Chip-Seq_TH2_Human | 2.71347189 |
17 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.68579568 |
18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.64381478 |
19 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.56949778 |
20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.50539462 |
21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.47765125 |
22 | MYC_22102868_ChIP-Seq_BL_Human | 2.40368343 |
23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.37216326 |
24 | MAF_26560356_Chip-Seq_TH1_Human | 2.29227409 |
25 | MYB_26560356_Chip-Seq_TH1_Human | 2.27990897 |
26 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.22738137 |
27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.07958646 |
28 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.05381886 |
29 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.03758183 |
30 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.95511412 |
31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.95140586 |
32 | UTX_26944678_Chip-Seq_JUKART_Human | 1.84808243 |
33 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.81314799 |
34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.79605220 |
35 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.79440059 |
36 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.77007629 |
37 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.76888813 |
38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.75135839 |
39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.72801411 |
40 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.72393639 |
41 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.68914469 |
42 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.58652179 |
43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.56538747 |
44 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.50286408 |
45 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.47325466 |
46 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.44020175 |
47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41683048 |
48 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.40360379 |
49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.39449328 |
50 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36946160 |
51 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.36567312 |
52 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.36327610 |
53 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32518359 |
54 | MAF_26560356_Chip-Seq_TH2_Human | 1.30166149 |
55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30119713 |
56 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.28711845 |
57 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.27265141 |
58 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.24935328 |
59 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.22971796 |
60 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.20475241 |
61 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.20475241 |
62 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.20475241 |
63 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.17865746 |
64 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.16144407 |
65 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.15401772 |
66 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12672160 |
67 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.10671493 |
68 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09494595 |
69 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.09160034 |
70 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.08612185 |
71 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.07582701 |
72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05620420 |
73 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03403530 |
74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03053167 |
75 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01696190 |
76 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.01526789 |
77 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99771881 |
78 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.98909586 |
79 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.98909586 |
80 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.98672889 |
81 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95086963 |
82 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.93992937 |
83 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93359514 |
84 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93117747 |
85 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91078586 |
86 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90465316 |
87 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89185177 |
88 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87917815 |
89 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87807074 |
90 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.87633218 |
91 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87621532 |
92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.87512742 |
93 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86396965 |
94 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.85846247 |
95 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.85479016 |
96 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85468692 |
97 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84381156 |
98 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.82693162 |
99 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82613397 |
100 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.82351441 |
101 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81012327 |
102 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80489623 |
103 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79468226 |
104 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.77032198 |
105 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.75950258 |
106 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75464692 |
107 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.74849253 |
108 | GATA1_22025678_ChIP-Seq_K562_Human | 0.74481570 |
109 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.74431077 |
110 | KDM2B_26808549_Chip-Seq_K562_Human | 0.74270825 |
111 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.74129918 |
112 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.73987660 |
113 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.73575140 |
114 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.72957010 |
115 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70519528 |
116 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.69675998 |
117 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.69401927 |
118 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.69053441 |
119 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.68586520 |
120 | CJUN_26792858_Chip-Seq_BT549_Human | 0.67694217 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000685_abnormal_immune_system | 3.78640352 |
2 | MP0003763_abnormal_thymus_physiology | 3.53912200 |
3 | MP0005671_abnormal_response_to | 3.46080830 |
4 | MP0005000_abnormal_immune_tolerance | 3.27130716 |
5 | MP0001790_abnormal_immune_system | 3.17536477 |
6 | MP0005387_immune_system_phenotype | 3.17536477 |
7 | MP0001800_abnormal_humoral_immune | 3.13950094 |
8 | MP0004947_skin_inflammation | 3.08523388 |
9 | MP0004510_myositis | 3.02606412 |
10 | MP0001835_abnormal_antigen_presentation | 2.95777790 |
11 | MP0003724_increased_susceptibility_to | 2.95453676 |
12 | MP0003436_decreased_susceptibility_to | 2.91041619 |
13 | MP0009785_altered_susceptibility_to | 2.79701659 |
14 | * MP0002723_abnormal_immune_serum | 2.76264416 |
15 | MP0003303_peritoneal_inflammation | 2.71521136 |
16 | MP0002138_abnormal_hepatobiliary_system | 2.70018157 |
17 | MP0006082_CNS_inflammation | 2.66993297 |
18 | MP0002452_abnormal_antigen_presenting | 2.66394833 |
19 | MP0002166_altered_tumor_susceptibility | 2.51180425 |
20 | MP0002420_abnormal_adaptive_immunity | 2.51076967 |
21 | MP0001819_abnormal_immune_cell | 2.50774248 |
22 | MP0002405_respiratory_system_inflammati | 2.48235533 |
23 | MP0002419_abnormal_innate_immunity | 2.36301146 |
24 | MP0002148_abnormal_hypersensitivity_rea | 2.32505365 |
25 | MP0002006_tumorigenesis | 2.29352755 |
26 | MP0005025_abnormal_response_to | 2.26409543 |
27 | MP0003300_gastrointestinal_ulcer | 2.16054838 |
28 | MP0002398_abnormal_bone_marrow | 2.07904373 |
29 | MP0009278_abnormal_bone_marrow | 2.05594243 |
30 | MP0000569_abnormal_digit_pigmentation | 1.98474443 |
31 | * MP0000716_abnormal_immune_system | 1.96421906 |
32 | MP0001873_stomach_inflammation | 1.93964370 |
33 | MP0002254_reproductive_system_inflammat | 1.88131205 |
34 | * MP0010155_abnormal_intestine_physiology | 1.85644799 |
35 | MP0009333_abnormal_splenocyte_physiolog | 1.84386482 |
36 | MP0001533_abnormal_skeleton_physiology | 1.84072928 |
37 | MP0001853_heart_inflammation | 1.82981325 |
38 | * MP0001845_abnormal_inflammatory_respons | 1.75495732 |
39 | MP0001851_eye_inflammation | 1.73458338 |
40 | MP0000703_abnormal_thymus_morphology | 1.70728570 |
41 | MP0005397_hematopoietic_system_phenotyp | 1.69482585 |
42 | MP0001545_abnormal_hematopoietic_system | 1.69482585 |
43 | MP0002722_abnormal_immune_system | 1.66628470 |
44 | MP0000689_abnormal_spleen_morphology | 1.64929360 |
45 | MP0000858_altered_metastatic_potential | 1.64887038 |
46 | MP0002277_abnormal_respiratory_mucosa | 1.58990971 |
47 | MP0005076_abnormal_cell_differentiation | 1.57714258 |
48 | MP0003448_altered_tumor_morphology | 1.55385489 |
49 | MP0005464_abnormal_platelet_physiology | 1.55379792 |
50 | MP0002998_abnormal_bone_remodeling | 1.53686546 |
51 | * MP0002429_abnormal_blood_cell | 1.52430301 |
52 | MP0010352_gastrointestinal_tract_polyps | 1.44051333 |
53 | MP0001501_abnormal_sleep_pattern | 1.42837014 |
54 | MP0003453_abnormal_keratinocyte_physiol | 1.31481505 |
55 | MP0003866_abnormal_defecation | 1.29648991 |
56 | MP0008469_abnormal_protein_level | 1.26904369 |
57 | MP0008004_abnormal_stomach_pH | 1.23888424 |
58 | MP0005310_abnormal_salivary_gland | 1.23091373 |
59 | MP0002009_preneoplasia | 1.20469141 |
60 | MP0003656_abnormal_erythrocyte_physiolo | 1.18886886 |
61 | MP0000604_amyloidosis | 1.14631637 |
62 | MP0008007_abnormal_cellular_replicative | 1.14188510 |
63 | MP0000465_gastrointestinal_hemorrhage | 1.13733660 |
64 | * MP0002933_joint_inflammation | 1.07604266 |
65 | MP0003091_abnormal_cell_migration | 1.04583103 |
66 | MP0002877_abnormal_melanocyte_morpholog | 1.03741411 |
67 | MP0005451_abnormal_body_composition | 0.98678022 |
68 | MP0004808_abnormal_hematopoietic_stem | 0.98396393 |
69 | MP0008961_abnormal_basal_metabolism | 0.98164772 |
70 | MP0002396_abnormal_hematopoietic_system | 0.97383128 |
71 | MP0000343_altered_response_to | 0.96882373 |
72 | MP0009764_decreased_sensitivity_to | 0.92243634 |
73 | MP0000249_abnormal_blood_vessel | 0.91716056 |
74 | MP0003172_abnormal_lysosome_physiology | 0.88694286 |
75 | MP0003075_altered_response_to | 0.88535748 |
76 | MP0005167_abnormal_blood-brain_barrier | 0.88156639 |
77 | MP0001191_abnormal_skin_condition | 0.87753361 |
78 | MP0005058_abnormal_lysosome_morphology | 0.87358610 |
79 | MP0002332_abnormal_exercise_endurance | 0.86301608 |
80 | MP0002060_abnormal_skin_morphology | 0.85735738 |
81 | MP0003828_pulmonary_edema | 0.83813809 |
82 | MP0003566_abnormal_cell_adhesion | 0.83388381 |
83 | MP0005390_skeleton_phenotype | 0.82813900 |
84 | MP0003045_fibrosis | 0.81311911 |
85 | MP0005174_abnormal_tail_pigmentation | 0.78910784 |
86 | MP0001919_abnormal_reproductive_system | 0.77362191 |
87 | MP0001881_abnormal_mammary_gland | 0.76548400 |
88 | MP0003183_abnormal_peptide_metabolism | 0.74013559 |
89 | MP0005164_abnormal_response_to | 0.72871215 |
90 | MP0003795_abnormal_bone_structure | 0.71962692 |
91 | MP0005166_decreased_susceptibility_to | 0.69716105 |
92 | MP0000490_abnormal_crypts_of | 0.69125358 |
93 | * MP0000609_abnormal_liver_physiology | 0.68292461 |
94 | * MP0009763_increased_sensitivity_to | 0.67948766 |
95 | MP0001663_abnormal_digestive_system | 0.67521469 |
96 | MP0001542_abnormal_bone_strength | 0.63830469 |
97 | * MP0001216_abnormal_epidermal_layer | 0.62454163 |
98 | * MP0002136_abnormal_kidney_physiology | 0.62243254 |
99 | MP0005023_abnormal_wound_healing | 0.61926885 |
100 | MP0004381_abnormal_hair_follicle | 0.61655424 |
101 | MP0001348_abnormal_lacrimal_gland | 0.60700856 |
102 | MP0009840_abnormal_foam_cell | 0.60689520 |
103 | MP0003191_abnormal_cellular_cholesterol | 0.60250373 |
104 | MP0002139_abnormal_hepatobiliary_system | 0.59273201 |
105 | MP0004883_abnormal_blood_vessel | 0.58471583 |
106 | MP0002928_abnormal_bile_duct | 0.57851445 |
107 | MP0008260_abnormal_autophagy | 0.57657823 |
108 | MP0005535_abnormal_body_temperature | 0.57112192 |
109 | MP0002019_abnormal_tumor_incidence | 0.56953382 |
110 | MP0009765_abnormal_xenobiotic_induced | 0.54543693 |
111 | MP0001502_abnormal_circadian_rhythm | 0.54461505 |
112 | MP0001727_abnormal_embryo_implantation | 0.53260230 |
113 | MP0003195_calcinosis | 0.52013530 |
114 | MP0000627_abnormal_mammary_gland | 0.51640449 |
115 | MP0000367_abnormal_coat/_hair | 0.50918371 |
116 | MP0002132_abnormal_respiratory_system | 0.48814087 |
117 | MP0008995_early_reproductive_senescence | 0.48436552 |
118 | MP0002693_abnormal_pancreas_physiology | 0.48384746 |
119 | MP0005165_increased_susceptibility_to | 0.44541761 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Stomatitis (HP:0010280) | 7.92085857 |
2 | Optic neuritis (HP:0100653) | 6.80149556 |
3 | Retrobulbar optic neuritis (HP:0100654) | 6.80149556 |
4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.16517036 |
5 | Orchitis (HP:0100796) | 6.14975024 |
6 | Myositis (HP:0100614) | 5.89330156 |
7 | Keratoconjunctivitis sicca (HP:0001097) | 4.53216734 |
8 | Pulmonary infiltrates (HP:0002113) | 4.33325731 |
9 | Arterial thrombosis (HP:0004420) | 4.22881259 |
10 | T lymphocytopenia (HP:0005403) | 4.14164171 |
11 | Eczematoid dermatitis (HP:0000976) | 4.13825548 |
12 | Keratoconjunctivitis (HP:0001096) | 4.11902181 |
13 | Mediastinal lymphadenopathy (HP:0100721) | 4.05803343 |
14 | Abnormality of T cell number (HP:0011839) | 4.04872296 |
15 | Vasculitis (HP:0002633) | 4.00511451 |
16 | Autoimmune hemolytic anemia (HP:0001890) | 3.87756402 |
17 | Recurrent abscess formation (HP:0002722) | 3.84528914 |
18 | Recurrent fungal infections (HP:0002841) | 3.82748623 |
19 | Severe combined immunodeficiency (HP:0004430) | 3.77312433 |
20 | Thyroiditis (HP:0100646) | 3.74312079 |
21 | Recurrent bacterial skin infections (HP:0005406) | 3.69932245 |
22 | Persistence of primary teeth (HP:0006335) | 3.59115506 |
23 | Increased density of long bones (HP:0006392) | 3.55633848 |
24 | Hemoptysis (HP:0002105) | 3.53607729 |
25 | Leukocytosis (HP:0001974) | 3.51061934 |
26 | IgM deficiency (HP:0002850) | 3.50471259 |
27 | Gastrointestinal infarctions (HP:0005244) | 3.45361814 |
28 | Combined immunodeficiency (HP:0005387) | 3.32147794 |
29 | Nasal polyposis (HP:0100582) | 3.29345209 |
30 | Abnormality of eosinophils (HP:0001879) | 3.27409602 |
31 | Recurrent viral infections (HP:0004429) | 3.16881785 |
32 | IgG deficiency (HP:0004315) | 3.07160465 |
33 | Abnormality of T cells (HP:0002843) | 3.05721311 |
34 | Recurrent bronchitis (HP:0002837) | 2.99757774 |
35 | Abnormality of the prostate (HP:0008775) | 2.94897798 |
36 | Gangrene (HP:0100758) | 2.89216193 |
37 | Pulmonary embolism (HP:0002204) | 2.84932560 |
38 | B lymphocytopenia (HP:0010976) | 2.84138372 |
39 | Abnormality of B cell number (HP:0010975) | 2.84138372 |
40 | Papilloma (HP:0012740) | 2.80571382 |
41 | Verrucae (HP:0200043) | 2.80571382 |
42 | Abnormality of the nasal mucosa (HP:0000433) | 2.80447685 |
43 | Eosinophilia (HP:0001880) | 2.77535886 |
44 | Meningitis (HP:0001287) | 2.76434519 |
45 | Gingivitis (HP:0000230) | 2.73257469 |
46 | Chronic diarrhea (HP:0002028) | 2.71352077 |
47 | Prostate neoplasm (HP:0100787) | 2.69954272 |
48 | Recurrent skin infections (HP:0001581) | 2.67757209 |
49 | Recurrent cutaneous fungal infections (HP:0011370) | 2.63738384 |
50 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.63738384 |
51 | Joint swelling (HP:0001386) | 2.62099589 |
52 | Dysostosis multiplex (HP:0000943) | 2.61954473 |
53 | Increased IgM level (HP:0003496) | 2.60533551 |
54 | Anorexia (HP:0002039) | 2.60083794 |
55 | Depressed nasal tip (HP:0000437) | 2.56406845 |
56 | Alveolar cell carcinoma (HP:0006519) | 2.56232180 |
57 | Abnormality of the nasal septum (HP:0000419) | 2.55403033 |
58 | IgA deficiency (HP:0002720) | 2.54737102 |
59 | Abnormality of the fingertips (HP:0001211) | 2.53179009 |
60 | Pustule (HP:0200039) | 2.53000500 |
61 | Anhidrosis (HP:0000970) | 2.48382874 |
62 | Abnormality of macrophages (HP:0004311) | 2.47940339 |
63 | Chronic obstructive pulmonary disease (HP:0006510) | 2.46710262 |
64 | Obstructive lung disease (HP:0006536) | 2.46710262 |
65 | Hematochezia (HP:0002573) | 2.45346244 |
66 | Encephalitis (HP:0002383) | 2.43809145 |
67 | Abnormality of the pericardium (HP:0001697) | 2.39220412 |
68 | Gastrointestinal stroma tumor (HP:0100723) | 2.38508602 |
69 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.38273116 |
70 | Periodontitis (HP:0000704) | 2.38088700 |
71 | Myocardial infarction (HP:0001658) | 2.37909779 |
72 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.37696711 |
73 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.37696711 |
74 | Abnormality of glycolipid metabolism (HP:0010969) | 2.37696711 |
75 | Increased IgE level (HP:0003212) | 2.35913440 |
76 | Chronic otitis media (HP:0000389) | 2.35851395 |
77 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.34527349 |
78 | Premature loss of primary teeth (HP:0006323) | 2.33881565 |
79 | Colitis (HP:0002583) | 2.26008048 |
80 | Granulocytopenia (HP:0001913) | 2.25835087 |
81 | Interstitial pulmonary disease (HP:0006530) | 2.25707436 |
82 | Agammaglobulinemia (HP:0004432) | 2.25426604 |
83 | Thrombophlebitis (HP:0004418) | 2.24458829 |
84 | Chest pain (HP:0100749) | 2.24444759 |
85 | Polyneuropathy (HP:0001271) | 2.22897709 |
86 | Abnormality of the pleura (HP:0002103) | 2.22669913 |
87 | Osteomyelitis (HP:0002754) | 2.22045632 |
88 | Parakeratosis (HP:0001036) | 2.21761081 |
89 | Abnormality of T cell physiology (HP:0011840) | 2.19190480 |
90 | Lymphopenia (HP:0001888) | 2.19165531 |
91 | Vacuolated lymphocytes (HP:0001922) | 2.17460230 |
92 | Panhypogammaglobulinemia (HP:0003139) | 2.13839870 |
93 | Keratitis (HP:0000491) | 2.13789464 |
94 | Papilledema (HP:0001085) | 2.12788754 |
95 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.11331486 |
96 | Restrictive lung disease (HP:0002091) | 2.11320261 |
97 | Gingival bleeding (HP:0000225) | 2.10478527 |
98 | Conical tooth (HP:0000698) | 2.10336326 |
99 | Glomerulopathy (HP:0100820) | 2.10142052 |
100 | Recurrent sinusitis (HP:0011108) | 2.09998669 |
101 | Inflammation of the large intestine (HP:0002037) | 2.09707725 |
102 | Autoimmune thrombocytopenia (HP:0001973) | 2.09121941 |
103 | Arthralgia (HP:0002829) | 2.06852316 |
104 | Slow saccadic eye movements (HP:0000514) | 2.06314035 |
105 | Episodic fever (HP:0001954) | 2.05745431 |
106 | Loss of speech (HP:0002371) | 2.01529706 |
107 | Emphysema (HP:0002097) | 1.99842954 |
108 | Urticaria (HP:0001025) | 1.98136141 |
109 | Epistaxis (HP:0000421) | 1.97138618 |
110 | Stomach cancer (HP:0012126) | 1.96114150 |
111 | Fatigue (HP:0012378) | 1.96060990 |
112 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.94506629 |
113 | Thick nail (HP:0001805) | 1.94261327 |
114 | Hypergammaglobulinemia (HP:0010702) | 1.92959626 |
115 | Vertigo (HP:0002321) | 1.92582579 |
116 | Gastrointestinal inflammation (HP:0004386) | 1.92101359 |
117 | Lymphoma (HP:0002665) | 1.92100532 |
118 | Spontaneous hematomas (HP:0007420) | 1.90980617 |
119 | Abnormality of the endocardium (HP:0004306) | 1.89377358 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TXK | 5.46763643 |
2 | MAP3K14 | 5.14726315 |
3 | MAP4K1 | 3.69213140 |
4 | IRAK3 | 3.33037328 |
5 | ITK | 3.31118417 |
6 | PRPF4B | 3.06343993 |
7 | TBK1 | 3.00848316 |
8 | IKBKE | 2.87575673 |
9 | JAK1 | 2.76228109 |
10 | TYK2 | 2.74793588 |
11 | TAOK3 | 2.63048466 |
12 | IKBKB | 2.58699962 |
13 | JAK3 | 2.57924864 |
14 | MAP3K13 | 2.43628406 |
15 | CHUK | 2.25151043 |
16 | STK10 | 2.02417491 |
17 | EPHB1 | 1.79458090 |
18 | TEC | 1.78990973 |
19 | BMPR2 | 1.73375478 |
20 | TSSK6 | 1.63124554 |
21 | IRAK4 | 1.58561265 |
22 | ZAP70 | 1.56436096 |
23 | TGFBR2 | 1.51460987 |
24 | MATK | 1.50072507 |
25 | EPHA3 | 1.49553981 |
26 | GRK6 | 1.46912901 |
27 | FGFR4 | 1.44613712 |
28 | HCK | 1.43911008 |
29 | MAP3K10 | 1.43698279 |
30 | LCK | 1.39110987 |
31 | BTK | 1.32171355 |
32 | RIPK4 | 1.30207504 |
33 | JAK2 | 1.26144064 |
34 | RPS6KA4 | 1.25149198 |
35 | CSK | 1.23154244 |
36 | MST4 | 1.21241061 |
37 | FGFR3 | 1.20002647 |
38 | PIM1 | 1.19309111 |
39 | TAOK2 | 1.19228774 |
40 | MARK3 | 1.15418181 |
41 | CAMKK2 | 1.13763439 |
42 | NLK | 1.12886280 |
43 | GRK7 | 1.12360284 |
44 | PASK | 1.11711256 |
45 | MAPK15 | 1.11586352 |
46 | PTK6 | 1.05438917 |
47 | PKN1 | 1.02763209 |
48 | SYK | 1.02521794 |
49 | SIK3 | 1.00474402 |
50 | SIK2 | 0.99507179 |
51 | CDC42BPA | 0.89890686 |
52 | BRD4 | 0.85238234 |
53 | CDK12 | 0.84694742 |
54 | CAMKK1 | 0.82487604 |
55 | PRKCQ | 0.80926322 |
56 | BLK | 0.80276190 |
57 | IRAK1 | 0.80109800 |
58 | KIT | 0.79286182 |
59 | MAP2K3 | 0.75689692 |
60 | TTN | 0.75314365 |
61 | GSK3A | 0.71046533 |
62 | PDGFRB | 0.65260870 |
63 | MELK | 0.64955634 |
64 | MAP3K11 | 0.63014622 |
65 | FES | 0.59116270 |
66 | MOS | 0.57648943 |
67 | MAP3K3 | 0.57613773 |
68 | MAPK11 | 0.57380480 |
69 | TESK2 | 0.56368910 |
70 | NEK9 | 0.55744259 |
71 | CSF1R | 0.54643277 |
72 | CDK6 | 0.54198266 |
73 | FGR | 0.52423399 |
74 | EIF2AK2 | 0.52290845 |
75 | PRKCH | 0.51345453 |
76 | HIPK2 | 0.50681949 |
77 | MAPK7 | 0.50331410 |
78 | LYN | 0.49719440 |
79 | TNK2 | 0.47575720 |
80 | RPS6KL1 | 0.47502103 |
81 | RPS6KC1 | 0.47502103 |
82 | MAP3K7 | 0.47128264 |
83 | MAPK12 | 0.45019695 |
84 | TYRO3 | 0.43318714 |
85 | RPS6KA6 | 0.42281064 |
86 | LRRK2 | 0.41863848 |
87 | DDR2 | 0.40238943 |
88 | RIPK1 | 0.39699726 |
89 | IGF1R | 0.38806936 |
90 | MAPKAPK2 | 0.38558723 |
91 | RPS6KA5 | 0.37079288 |
92 | MARK2 | 0.37048241 |
93 | EGFR | 0.35655548 |
94 | TLK1 | 0.35134402 |
95 | INSR | 0.34896071 |
96 | ADRBK2 | 0.34382721 |
97 | PIM2 | 0.33452427 |
98 | RPS6KA1 | 0.32996631 |
99 | RPS6KA2 | 0.32535714 |
100 | IRAK2 | 0.30859055 |
101 | MAPK3 | 0.30733223 |
102 | CDK9 | 0.30347202 |
103 | PDK1 | 0.30259711 |
104 | CLK1 | 0.29669124 |
105 | STK11 | 0.29259585 |
106 | BMX | 0.29048252 |
107 | ABL1 | 0.28726500 |
108 | TAOK1 | 0.28522397 |
109 | NEK6 | 0.28434605 |
110 | MAPK4 | 0.27978504 |
111 | CDK4 | 0.26566836 |
112 | SIK1 | 0.26457686 |
113 | TRIB3 | 0.26385206 |
114 | RET | 0.25945802 |
115 | MAPK1 | 0.25901011 |
116 | FYN | 0.25166346 |
117 | MAPKAPK5 | 0.25035623 |
118 | SGK3 | 0.24684456 |
119 | PRKAA2 | 0.23795008 |
120 | DMPK | 0.22536231 |
121 | SGK1 | 0.22072226 |
122 | ERN1 | 0.22003178 |
123 | MAPK8 | 0.21550053 |
124 | ALK | 0.18957391 |
125 | TRPM7 | 0.17002888 |
126 | MAP3K1 | 0.16878907 |
127 | MAP2K2 | 0.16779150 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.57953365 |
2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.06672287 |
3 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.06581076 |
4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.86919885 |
5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.84014665 |
6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.76720749 |
7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.51088476 |
8 | Allograft rejection_Homo sapiens_hsa05330 | 2.44964528 |
9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.38151403 |
10 | * Measles_Homo sapiens_hsa05162 | 2.33428962 |
11 | * TNF signaling pathway_Homo sapiens_hsa04668 | 2.30290127 |
12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.16501869 |
13 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.15497898 |
14 | Toxoplasmosis_Homo sapiens_hsa05145 | 2.00210499 |
15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.94454171 |
16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.87654092 |
17 | Legionellosis_Homo sapiens_hsa05134 | 1.86249924 |
18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.76109184 |
19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.72186834 |
20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.68678571 |
21 | Influenza A_Homo sapiens_hsa05164 | 1.62502201 |
22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.52815627 |
23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.46980262 |
24 | Apoptosis_Homo sapiens_hsa04210 | 1.44544682 |
25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.42657419 |
26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42253642 |
27 | Malaria_Homo sapiens_hsa05144 | 1.41927250 |
28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.39535107 |
29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.38330855 |
30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.36812935 |
31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.35887473 |
32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.29275588 |
33 | Hepatitis B_Homo sapiens_hsa05161 | 1.29179178 |
34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.29075728 |
35 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.27792368 |
36 | Asthma_Homo sapiens_hsa05310 | 1.26850186 |
37 | Tuberculosis_Homo sapiens_hsa05152 | 1.26504451 |
38 | Pertussis_Homo sapiens_hsa05133 | 1.25776076 |
39 | Shigellosis_Homo sapiens_hsa05131 | 1.24704288 |
40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.20177784 |
41 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.19982067 |
42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.17161727 |
43 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.15963936 |
44 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14647664 |
45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.12602248 |
46 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.11926565 |
47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.09879484 |
48 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.06633305 |
49 | Circadian rhythm_Homo sapiens_hsa04710 | 1.04056368 |
50 | Hepatitis C_Homo sapiens_hsa05160 | 1.01268143 |
51 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.98965429 |
52 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96406180 |
53 | Salmonella infection_Homo sapiens_hsa05132 | 0.95343316 |
54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.94285707 |
55 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.89303008 |
56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.86458632 |
57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.84934024 |
58 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.83901872 |
59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82742430 |
60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79814836 |
61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.78609828 |
62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76504528 |
63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.75648978 |
64 | Platelet activation_Homo sapiens_hsa04611 | 0.74770905 |
65 | Insulin resistance_Homo sapiens_hsa04931 | 0.71806559 |
66 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.71530991 |
67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.68594119 |
68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.67026700 |
69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65465550 |
70 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64700236 |
71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.62802281 |
72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.61142345 |
73 | Endocytosis_Homo sapiens_hsa04144 | 0.61115212 |
74 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56970329 |
75 | Amoebiasis_Homo sapiens_hsa05146 | 0.52439924 |
76 | Prostate cancer_Homo sapiens_hsa05215 | 0.50927363 |
77 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48191271 |
78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47395001 |
79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47263915 |
80 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.46692140 |
81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46310607 |
82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.45653532 |
83 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45090083 |
84 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44278611 |
85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40501386 |
86 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39456439 |
87 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.36407402 |
88 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35079554 |
89 | Pathways in cancer_Homo sapiens_hsa05200 | 0.33633277 |
90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.33300383 |
91 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.33183668 |
92 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.32801571 |
93 | Lysosome_Homo sapiens_hsa04142 | 0.32703839 |
94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.32105424 |
95 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.31758497 |
96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30864725 |
97 | Prion diseases_Homo sapiens_hsa05020 | 0.30248704 |
98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.29404773 |
99 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.29122078 |
100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.28647648 |
101 | Bladder cancer_Homo sapiens_hsa05219 | 0.28542726 |
102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27661222 |
103 | Focal adhesion_Homo sapiens_hsa04510 | 0.27615827 |
104 | Phagosome_Homo sapiens_hsa04145 | 0.27106488 |
105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.26937093 |
106 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.25841757 |
107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.24895941 |
108 | Endometrial cancer_Homo sapiens_hsa05213 | 0.24567197 |
109 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.24157662 |
110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.23555664 |
111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.20028105 |